To investigate how FXR was involved in arsenic-induced glucose intolerance, we designed the second stage of the animal experiment to inspect if the introduction of a FXR agonist could reverse the arsenic-induced glucose intolerance (Figure 1B). The gene discussed is NR1H4; the disease is Glucose intolerance.